Highlights
1 patent
About
Drug Discovery Platform for Novel Oral Drugs
ProMining Therapeutics Ltd discovers and develops novel oral, small-molecule drugs for the treatment of cancer, inflammation, chronic pain, and cardiovascular and viral diseases. The company developed CavitIIRx, a proprietary drug-discovery and development platform focused on SH3 domain-mediated proteinprotein interactions known to play a major role in numerous disease mechanisms. ProMining uses its innovative platform to discover promising drug candidate molecules, creating a pipeline of drugs in development and accelerating the drug-discovery process.
Identity
| Name | ProMining Therapeutics |
|---|---|
| Slug | promining-therapeutics |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7R9fcKDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Dec 2015 |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ness Ziona |
| HQ address | Pinhas Sapir Street 3, Ness Ziyyona, Israel |
Web & social
| https://www.linkedin.com/company/5736786 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
viral-diseasesdrug-discoverychronic-paintargeted-cancer-therapycardiovascularpharma-companiescardiology
Funding
| Total raised | — |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}